Review articleOsteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
References (118)
- et al.
Augmented trochanteric bone mineral density after modified physical education classes: A randomized school-based exercise intervention study in prepubescent and early pubescent children
J Pediatr.
(2000) - et al.
Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants
Am J Clin Nutr
(1994) - et al.
Mortality after all major types of osteoporotic fracture in men and women: An observational study
Lancet
(1999) - et al.
The components of excess mortality after hip fracture
Bone
(2003) - et al.
Physiological senile involution and pathological rarefraction of bone. Quantitative and comparative histological data
Clin Endocrinol Metab
(1973) - et al.
Preliminary evidence for impaired estrogen receptor-alpha protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis
Bone
(2000) - et al.
The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis Study
Bone
(1997) - et al.
Utility of medical and drug history in fracture risk prediction among men and women
Bone
(2002) - et al.
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
N Engl J Med
(1997) - et al.
Osteoporosis in elderly men and women: Effects of dietary calcium, physical activity, and body mass index
J Bone Miner Res
(2000)
Physical activity and osteoporotic hip fracture risk in men
Arch Intern Med
(2000)
Exercise and other factors in the prevention of hip fracture: The Leisure World study
Epidemiology
(1991)
Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial
JAMA
(1994)
Alendronate for the treatment of osteoporosis in men
N Engl J Med
(2000)
Alendronate treatment of established primary osteoporosis in men: Results of a 2-year prospective study
J Clin Endocrinol Metab
(2001)
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
N Engl J Med
(1998)
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial
Arthritis Rheum
(2001)
A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis. Effects on bone mineral density and bone markers
J Bone Miner Res
(2002)
The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis
J Bone Miner Res
(2003)
Prevalence of low femoral bone density in older US adults from NHANES III
J Bone Miner Res
(1997)
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: The Canadian Multicentre Osteoporosis Study (CaMos)
Osteoporos Int
(2000)
During aging, men lose less bone than women because they gain more periosteal bone, not because they resorb less endosteal bone
Calcif Tissue Int
(2001)
Prevalence and severity of vertebral fracture: The Saunders County Bone Quality Study
Osteoporos Int
(1996)
Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES)
Osteoporos Int
(1994)
Bone density variation and its effect on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS Study
J Bone Miner Res
(1997)
Vertebral fracture definition from populationbased data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos)
Osteoporos Int
(2000)
The prevalence of vertebral deformity in European men and women. The European Vertebral Osteoporosis Study
J Bone Miner Res
(1996)
Gender differences in vertebral sizes in adults. Biomechanical implications
Radiology
(1994)
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada
Osteoporos Int
(2001)
Risk factors for hip fracture in white men: The NHANES I Epidemiologic Follow-up Study
J Bone Miner Res
(1998)
Sex-specific and race-specific hip fracture rates
Am J Public Health
(1990)
World-wide projections for hip fracture
Osteoporos Int
(1997)
Current and projected rates of hip fracture in Canada
CMAJ
(1997)
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: A 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study
Osteoporos Int
(2003)
Survival and potential years of life lost after hip fracture in men and age-matched women
Osteoporos Int
(2002)
Survival after hip fracture: Short- and long-term excess mortality according to age and gender
Osteoporos Int
(1999)
Race and sex differences in mortality following fracture of the hip
Am J Public Health
(1992)
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
J Bone Miner Res
(1997)
An assessment of the burden of illness due to osteoporosis in Canada
J Soc Gynaecol Can
(1996)
Economic implications of hip fracture: Health service use, institutional care and cost in Canada
Osteoporos Int
(2001)
Osteoporosis in men
Endocr Rev
(1995)
Pathogenesis of vertebral crush fractures in men
Age Ageing
(1992)
Calcium accretion in girls and boys during puberty: A longitudinal analysis
J Bone Miner Res
(2000)
The microanatomy of trabecular bone loss in normal aging men and women
Clin Orthop
(1987)
Age related histomorphometric changes in bone in normal British men and women
J Clin Pathol
(1994)
Structural trends in the aging femoral neck and proximal shaft: Analysis of the Third National Health and Nutrition Examination Survey dual-energy x-ray absorptiometry data
J Bone Miner Res
(2000)
Age-related changes in bobe turnover in men
J Bone Miner Res
(1999)
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
J Clin Endocrinol Metab
(1998)
Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling
J Clin Endocrinol Metab
(1989)
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer
N Engl J Med
(2001)
Cited by (147)
Bone mineral acquisition in utero and during infancy and childhood
2020, Marcus and Feldman’s OsteoporosisMolecular mechanism of action of Liuwei Dihuang pill for the treatment of osteoporosis based on network pharmacology and molecular docking
2020, European Journal of Integrative MedicineCitation Excerpt :The pathogenesis of osteoporosis is very complex and includes the interaction of endocrine, nutritional, genetic, physical and immune factors [2]. Modern Western medicine treats osteoporosis mainly through drug therapy and lifestyle changes, including mineral supplementation, diet improvement and a personalized exercise program [3,4]. Only 9 drugs, such as Alendronic acid and Ibandronate, have been approved by the US Food and Drug Administration for the prevention and treatment of osteoporosis.
Distal radial fractures in older men: A missed opportunity?
2014, Journal of Bone and Joint Surgery - American VolumeFragility fractures: Risk factors and management strategies
2023, Advances in Health and Disease
Copyright © 2004 Published by Elsevier Inc.